{"id":"W2210617513","doi":"10.1155/2007/161652","title":"Treatment Persistence and Compliance with Medications for Chronic Obstructive Pulmonary Disease","year":2007,"lang":"en","type":"article","venue":"Canadian Respiratory Journal","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada); Boehringer Ingelheim (Canada)","funders":"Pfizer Canada; Pfizer","keywords":"Medicine; Salmeterol; Ipratropium bromide; Ipratropium; Formoterol; Budesonide/formoterol; COPD; Tiotropium bromide; Asthma; Discontinuation; Salbutamol; Budesonide; Persistence (discontinuity); Internal medicine; Fluticasone; Inhaler; Bronchodilator","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002418849,0.0002197408,0.0002497594,0.0003793216,0.0006463668,0.00004817298,0.0001415594,0.0000680205,0.0001814564],"category_scores_gemma":[0.00006300741,0.0001799405,0.0001085951,0.0002389141,0.0005446622,0.0001604185,0.00001448853,0.000285475,0.00001062231],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004336604,"about_ca_system_score_gemma":0.007275538,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005821287,"about_ca_topic_score_gemma":0.009089986,"domain_scores_codex":[0.9982225,0.00004024888,0.0002655394,0.000382095,0.0003530988,0.0007365763],"domain_scores_gemma":[0.995414,0.0001051669,0.0001041052,0.0003277277,0.0003812399,0.003667716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002607553,0.0003520357,0.645962,0.0008415788,0.0009193364,0.01453639,0.0005808097,0.00004397924,0.001343129,0.0021942,0.0007306393,0.3298883],"study_design_scores_gemma":[0.001938995,0.000487602,0.9317849,0.0001958716,0.0002929978,0.00153918,0.0007905886,0.0003654785,0.00006259444,0.0002090674,0.06211064,0.0002220769],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9606829,0.02620863,0.001182249,0.004296459,0.0002388025,0.001995336,0.0004198122,0.00003946579,0.004936398],"genre_scores_gemma":[0.9973205,0.00009427871,0.0005075373,0.0005253489,0.0006794278,0.00007066967,0.000024537,0.00004223834,0.0007354299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3296663,"threshold_uncertainty_score":0.9994856,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04851666951544207,"score_gpt":0.3109283108508119,"score_spread":0.2624116413353698,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}